Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report.
about
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomesMultiple Factors Related to the Secretion of Glucagon-Like Peptide-1Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load in humansSafety and efficacy of acarbose in the treatment of diabetes in Chinese patients.Cardiovascular safety profile of currently available diabetic drugs.Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed mealAcarbose Decreases the Rheumatoid Arthritis Risk of Diabetic Patients and Attenuates the Incidence and Severity of Collagen-induced Arthritis in MiceEffect of Acarbose on Long-Term Prognosis in Acute Coronary Syndromes Patients with Newly Diagnosed Impaired Glucose Tolerance.Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot studyUntapped diamonds for untamed diabetes: The α-glucosidase inhibitorsAcarbose Accelerates Wound Healing via Akt/eNOS Signaling in db/db Mice.On the potential of acarbose to reduce cardiovascular disease.Acarbose monotherapy and weight loss in Eastern and Western populations with hyperglycaemia: an ethnicity-specific meta-analysis.Inhibiting or antagonizing glucagon: making progress in diabetes care.Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis.Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis.Associations between changes in glucagon-like peptide-1 and bodyweight reduction in patients receiving acarbose or metformin treatment.Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study.α-Glucosidase inhibitory activity of protein-rich extracts from extruded adzuki bean in diabetic KK-Ay mice.Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions.
P2860
Q26778095-02F77B51-85FC-471D-9172-A8B63AA675E2Q26781127-16C8E64D-E355-48CE-9E7D-6F0965488B7AQ33356608-FD8DFBB7-DF6E-49C4-8FA7-326AED3EADC8Q33857845-1883CB25-E98A-4C08-B794-3DA41899F662Q34971736-376A1ED5-EFF1-477D-AC68-B3064CA8157AQ35047406-A595ABA5-57FB-4A4E-B943-DA21514B4854Q36148983-1A35CEA1-1CEF-4757-BA4E-722AB0663FC8Q36382309-6B6A6DB8-AD53-455E-B7F6-25B6869B244DQ36386631-9D3D4519-2145-42F4-9AD2-37E3CA14E664Q37627628-3DE64614-A898-4C70-9EAE-D728132DEF94Q37703682-3427E7CE-9E3F-4F5D-A4D7-37FACA2F2762Q37714714-81513A47-AE09-49E3-8008-9AB1C4CAF635Q37717838-E5B39319-2D83-44D4-B332-830C8B3CA0FFQ38213904-4686B74D-F649-4C96-A039-20CD8DA7B753Q38449296-6E22900B-2238-468E-AFF4-BE2B5D9E62E4Q38563239-8F39110F-C8AB-4979-BCFF-27D15FEE3BFAQ45783993-5EA5F13A-C45B-4D42-8612-5C0061B86145Q47918382-493C276D-3027-4F14-B4D4-BCBAB090016AQ51278212-65FBA90C-A20F-4A29-B22D-19B23E506C59Q51321908-19550C1F-0D25-4DCA-A3A8-0805DB41D850Q51325897-88405AE0-E24C-484A-8D61-FF976CB3305EQ52673331-DC1AB659-8F76-484B-AC83-182FADB4784D
P2860
Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of 24-week treatment w ...... atients: a preliminary report.
@en
type
label
Effects of 24-week treatment w ...... atients: a preliminary report.
@en
prefLabel
Effects of 24-week treatment w ...... atients: a preliminary report.
@en
P2093
P2860
P356
P1476
Effects of 24-week treatment w ...... atients: a preliminary report.
@en
P2093
Bao-cheng Chang
Chun-yan Shan
Hong-tao Zhou
Hui-zhu Ren
Ju-hong Yang
Li-ming Chen
Miao-yan Zheng
Yan-guang Xu
P2860
P2888
P356
10.1186/1475-2840-12-73
P407
P577
2013-05-04T00:00:00Z
P5875
P6179
1016205949